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Abstract 13 
Arthropods can produce a wide range of antifungal compounds including specialist proteins, cuticular 14 
products, venoms and haemolymphs. In spite of this, many arthropod taxa, particularly eusocial 15 
insects, make use of additional antifungal compounds derived from their mutualistic association with 16 
microbes. Because multiple taxa have evolved such mutualisms it must be assumed that, under certain 17 
ecological circumstances, natural selection has favoured them over those relying upon endogenous 18 
antifungal compound production. Further, such associations have been shown to persist versus 19 
specific pathogenic fungal antagonists for more than 50 million years, suggesting that compounds 20 
employed have retained efficacy in spite of the pathogens’ capacity to develop resistance. We provide 21 
a brief overview of antifungal compounds in the arthropods’ armoury, proposing a conceptual model 22 
to suggest why their use remains so successful. Fundamental concepts embedded within such a model 23 







1. Introduction 29 
Resistance to antifungal compounds is constantly rising to the point at which it is a critical factor in 30 
determining medical policy (Wiederhold 2017).  To cope with this crisis, during the last 30 years 31 
several techniques have been employed in order to find new antifungals, including genome mining, 32 
synthetic biology, and exploring alternative microbial sources, such as marine microbes, and 33 
underrepresented taxa (Chevrette et al. 2019 and references within). Despite such efforts, 34 
identification and development of new antifungals has showed limited success. During the last 35 
decades research has demonstrated that animal taxa such as the Arthropoda have been using 36 
antifungals for millions of years. Arthropods produce endogenous antimicrobial compounds or can 37 
make use of those produced by bacterial mutualists (Shanchez-Contreras and Vlisidou 2008). 38 
Arthropods are highly speciose, occupy many trophic levels within a wide range of heterogeneous 39 
ecosystems and offer a wide array of molecules and interactions for research.  40 
 41 
As microorganisms and arthropods co-evolved, production of antifungals was influential in defining 42 
ecological roles and interactions (Heine et al. 2018). Their secondary metabolites served to enable 43 
competition with other arthropods, to resist pathogens and, ultimately, to support growth and 44 
reproduction (Rohlfs and Churchill 2011). Thus, the tight regulatory control of antifungal metabolite 45 
formation in some model fungi represents an evolved chemical defence system favoured by selection 46 
not only against parasites but also animal antagonists (Rohlfs and Churchill 2011). The main use of 47 
such antifungals is to improve fitness but how they achieve their effects has not been fully resolved. 48 
This is particularly true in case of the apparent lack of development of antifungal resistances by 49 
parasitic antagonists.  50 
We propose a conceptual strategy of antifungal use in arthropods employing two main resources: 51 
endogenous antifungal peptides and antifungal-producing bacteria. Strategic knowledge acquired via 52 
observing these natural systems may offer insights by which to combat not only antifungal resistance 53 
but also to prevent development of resistances against antimicrobials in general (Hokken et al. 2019). 54 
Current analysis of arthropods and their mutualists offers many specific examples to indicate that such 55 
interactions provide an immense reservoir of potential antifungal compounds, but, more importantly, 56 
 
 3 
these systems have much to teach us about fine regulation and long-term strategic employment of  57 
such important molecules (Figure 1).  58 
 59 
2. Setting the scene: Arthropods use both endogenously and microbially-produced antifungals 60 
This section reviews arthropod and associated microbial antifungal production  to contextualise 61 
conceptual models put forward in this paper. 62 
 63 
2.1 Production of endogenous antifungals by arthropods  64 
Arthropods secrete a wide array of secondary metabolites via their exocrine glands. Some of these 65 
secretions are used to communicate with conspecifics (sex, social, etc), others serve as food for 66 
developing offspring whilst yet others are used to defend single individuals or their societies from 67 
enemies and pathogens, including entomopathogenic fungi and Microsporidia (Schultz and Brady 68 
2008; Mylonakis et al. 2016). 69 
It has been long established  that insect outer cuticle forms the first barrier to fungal infection, having 70 
either a fungicidal or fungistatic action (Koidsumi 1957, Ortiz et al. 2013). This thin layer is produced 71 
by cuticular glands  and is composed of a complex mixture of lipids, including abundant straight-72 
chain and methyl-branched, saturated and unsaturated hydrocarbons acting as a primary defence 73 
against fungi (Pedrini et al. 2013). Cuticle-degrading enzymes and enzyme-resistant cuticles both 74 
evidence the significance of an ongoing arms race between insects and entomopathogenic fungi 75 
(Zhang et al 2012, Pedrini et al. 2015). 76 
Most exocrine glands with a known specific defensive function are those of social insects (Wilson and 77 
Holldobler 2005). Many ants species’ metapleural gland secretions (for example) inhibit not only the 78 
growth of various bacteria but also that of some fungi, including entomopathogenic ones (Beattie 79 
1985; Veal, Stokes, and Daggard 1992; Rothberg et al. 2011). Various compounds such as 3-80 
hydroxydecanoic acid, indoleacetic acid and phenylacetic acid secreted by the leafcutter ant, 81 
Acromyrmex octospinosus, metapleural glands are effective against the parasitic fungus Escovopsis 82 
but also against their mutualistic fungus (Leucoagaricus gongillophorus) (Nascimento et al. 1996; Bot 83 
et al. 2002). Hymenopteran venoms can contain antibacterial and antifungal compounds such as 84 
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melectin and halictines (Slaninova et al. 2011). For example, ponericins from the venom of the 85 
ponerine ant Pachicondyla gueldi, can be active against bacteria and yeasts (Orivel et al. 2001), 86 
unidentified toxins in the venom of the paper wasp Polistes flavus are active against Candida and 87 
Aspergillus niger (Prajapati and Upadhyay 2016), while the venom of Apis mellifera and of a sweat 88 
bee is active against Candida (Ferrell et al. 2015; Lee 2016).  The termite Pseudacanthotermes 89 
spiniger (Silva et al. 2003) produces a compound called termicin, to defend their colonies from 90 
pathogenic fungi whilst  a small antimicrobial peptide within royal jelly (Jelleine-I) presents potent in 91 
vitro and in vivo antifungal activity (Jia et al. 2018).  92 
Antifungal substances are also produced in the haemolymph of non-social insects when induced by a 93 
fungal infection. Drosomycin has been extracted from the haemolymph of the fly Drosophila 94 
melanogaster (Zhang et al. 2009), while the spined soldier bug Podisus maculiventris  (Hemiptera) 95 
produces thanatin (Sinha et al. 2017). The haemolymphs of various Lepidoptera contain antifungal 96 
substances such as the gallerimycin from Galleria mellonella (Schuhmann et al. 2003).  97 
Arthropods other than insects are known to produce antifungal active substances especially in venom, 98 
for example tenecin is an anti-microbial peptide (AMP) found in the venom of the Brazilian yellow 99 
scorpion Tityus serrulatus (Santussi et al. 2017) and joruin is produced in the haemolymph of the 100 
Amazonian pink toe spider Avicularia juruensis (Ayroza et al. 2012).  101 
 102 
2.2 Arthropod-associated bacteria and symbiotically-produced antifungals 103 
Arthropods’ exosymbiotic and endosymbiotic bacteria form co-evolutionary associations ranging 104 
from facultative to obligate mutualisms (Chen et al. 2017; Shanchez-Contreras and Vlisidou 2008). 105 
They can fulfil a variety of roles including improving nutrient acquisition, facilitating development of 106 
resistance to plant secondary metabolites and assisting chemical pollutant and pesticide detoxification 107 
(Boucias et al. 2018). Some bacterial symbionts can also produce antifungals evolved to limit 108 
replication of the arthropods’ fungal antagonists (Holmes et al. 2016).   109 
 110 
Fungus farming termites of sub-family Macrotermitinae and fungus farming ants of genus 111 
Acromyrmex exemplify such microorganism-insect associations. Both cultivate specific fungi as 112 
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colony food source and their bacterial mutualists produce antifungals to protect the cultivar. Some 30 113 
million years ago Macrotermitinae termites (of which there are some 350 species) evolved the 114 
cultivation of basidiomycetes within the genus Termitomyces as their primary food source (Otani et 115 
al. 2014; Lever et al. 2015; Aanen et al. 2002). Termitomyces is subject to parasitism by opportunistic 116 
fungi belonging to the genus Pseudoxylaria spp. and competition from fungi such as Trichoderma or 117 
Beauveria (Um et al. 2013; Otani et al. 2019; Katariya et al. 2017; Katariya, Ramesh, and Borges 118 
2018). It is likely that the Macrotermitinae employ multiple strategies to control such antagonists and 119 
production of antifungals is one of them (Katariya et al. 2017; Um et al. 2013). So far, seven 120 
prokaryotic phyla have been identified in the Macrotermitinae’s gut flora (Otani et al. 2014). Among 121 
them Bacillus strains are dominant and can produce antifungals. An initial liquid chromatography and 122 
mass spectrometry (LC/MS) analysis of an extract of the Bacillus strains cultures revealed a major 123 
secondary metabolite: bacillaene, a polyene polyketide, common to all strains, which inhibits the 124 
growth of Pseudoxylaria, Trichoderma, Coriolopsis, Umbelopsis and Fusarium in a dose-dependent 125 
manner (Um et al. 2013). Fungus-growing termites also support Streptomyces which produce the 126 
antifungal natalamycin (Kim et al. 2014). The Streptomyces strain associated with fungus-growing 127 
termites also produces additional antibiotics: microtermolides A and B (Carr et al. 2012). 128 
A similar association occurs in leafcutter ant, Acromyrmex spp. colonies.  Acromyrmex cultivate a 129 
fungal mutualist, Leucoagaricus gongylophorus as their sole source of nutrition and support 130 
Pseudonocardia bacteria within their metapleural glands (Heine et al. 2018; Holmes et al. 2016). The 131 
L. gongylophorus cultivar is parasitized by another fungus: Escovopsis (Schultz and Brady 2008; Yek, 132 
Boomsma, and Poulsen 2012). The Pseudonocardia synthesize different variants of the broad-133 
spectrum polyene antifungal nystatin P1 to control Escovopsis (Holmes et al. 2016). In addition, 134 
Pseudonocardia associated with the attines Apterostigma dentigerum and Trachymyrmex cornetzi 135 
have recently been found to produce novel cyclic depsipeptide compounds called gerumycins A-C, 136 
(Holmes et al. 2016). The gerumycins are slightly smaller versions of dentigerumycin, a cyclic 137 
depsipeptide that, at micromolar concentrations, also selectively inhibits  Escovopsis (Sit et al. 2015) 138 
without affecting the ants’ fungal cultivar (Oh et al. 2009). In contrast, purified gerumycin A did not 139 
exhibit significant antifungal activity in vitro up to 1 mM against a dentigerumycin-sensitive strain, 140 
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and phenotypic screening of the gerumycin-producing bacteria against Escovopsis did not display 141 
marked activity, indicating that dentigerumycin is at least three orders of magnitude more potent than 142 
the gerumycins at suppressing Escovopsis (Sit et al. 2015). Such differences in potency may form the 143 
basis of a strategy inhibiting development of resistance wherein different antifungal variants may be 144 
effective against different species of Escovopsis and do not act as general purpose antifungals (Baym, 145 
Stone, and Kishony 2016). 146 
Streptomyces are commonly found in insect microbiomes:  southern pine beetle (Dendroctonus 147 
frontalis) exhibits mutualism with Streptomyces, strains of which produce a number of secondary 148 
metabolites including frontalamide A, frontalamide B, and mycangimycin (Scott et al. 2008; Blodgett 149 
et al. 2010). Mycangimycin inhibits the beetles’ antagonistic fungus Ophiostoma minus and has 150 
potent inhibitory activity against Plasmodium falciparum, whilst frontalamides have general 151 
antifungal activity (Scott et al. 2008; Blodgett et al. 2010; Baniecki, Wirth, and Clardy 2007). 152 
Streptomyces spp. are also associated with the solitary wasps, Sceliphron caementarium, and 153 
Chalybion californicum, providing antibacterial and antifungal chemical protection to their larvae via 154 
production of streptochlorin, and a variety of piericidin analogues (Poulsen et al. 2011). The 155 
antifungal compound sceliphrolactam was isolated from Streptomyces associated with the mud dauber 156 
wasp Sceliphron caementarium (Poulsen et al. 2011). The compound is a polyene macrocyclic lactam 157 
displaying antifungal activity against amphotericin B-resistant Candida albicans (Oh et al. 2011). 158 
Screening for novel antimicrobials produced by actinobacteria, revealed a kanchanamycin-producing 159 
actinomycete with antifungal activity isolated from the head of Lasius fuliginosus L. (Ye et al. 2017). 160 
Similarly, another actinomycete,  isolated from the head of the Japanese carpenter ant Camponotus 161 
japonicas exhibits specific antifungal activity against the plant-pathogens Phytophthora infestans and 162 
Corynespora cassiicola (Bai et al. 2016; Bowen et al. 2018; Izbiańska et al. 2019).  Even 163 
entomopathogenic fungi can produce antifungal peptides to combat their own fungal antagonists; 164 
conidial cell walls of the insect pathogen fungus, Beauveria bassiana, express and release an 165 
antifungal peptide (BbAFP1) into surrounding microenvironments, inhibiting growth of other, 166 




3.  An antifungals arms race: mix to evolve, evolve to mix.  169 
Complex organisms’ main defence against pathogens is their immune system. Antifungal molecules 170 
are integral components of the innate immune system in many taxa. Mammalian antifungal peptides 171 
such as defensins, protegrins, histatins, lactoferricins as well as antifungal peptides produced by birds, 172 
amphibians and insects all play pivotal roles in fighting fungal pathogens (Neelabh, Singh, and Rani 173 
2016; Hegedüs and Marx 2013). 174 
This being so, it begs a question; if such organisms have evolved to produce their own antifungal 175 
compounds why have some arthropods, notably those associated with specific fungal mutualists, 176 
evolved further mutualisms with bacteria that provide their hosts with additional antifungal 177 
compounds? The answer may lie in the development of resistances by their fungal antagonists. 178 
Antifungal compounds, mainly peptides or proteins have been proposed as a primitive mechanism of 179 
immunology (Hegedüs and Marx 2013) and there are no doubts about their potency, but small 180 
changes in fungal antagonists’ epitope can inhibit or eliminate their efficacy. Thus, in such cases, how 181 
does participation in such mutualistic associations avoid development of antifungal resistances, whilst 182 
possession of integral antifungal peptides alone does not?  183 
 184 
Attine ants (tribe: Attini) provide a useful model by which to examine these questions. To counter the 185 
threat of pathogenic infection of their garden fungus, the attines have multiple strategies including a 186 
tripartite mutualistic relationship within which they host antibiotic-producing bacteria on their bodies 187 
(Barke et al. 2010). Many of these bacteria have coevolved with their hosts, producing antifungals to 188 
inhibit parasitic fungi (Escovopsis spp. and allied taxa) whilst in return, the ants feed them via unique 189 
exocrine glands within elaborate cuticular crypts that also offer the bacteria their favoured 190 
microclimate (Currie et al. 2006). For the attine:cultivar association to have persisted for 50 million 191 
years in the face of Escovopsis parasitism, it suggests that any resistance Escovopsis evolves to 192 
antifungals employed against it must be countered by a similar flexibility in antifungal innovation on 193 
the part of the multi-partite mutualists. It is this flexibility, essential in a fast moving, co-evolutionary 194 
conflict between mutualists and parasite, that the bacteria provide. In the example of the attine 195 
cultivar, comparing molecular structures of different gerumycins and dentigerumycin variations 196 
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produced by different Pseudonocardia associated with two different attine genera (Sit et al. 2015) 197 
suggests pathways via which closely related symbiotic bacteria acquire the capacity to produce novel 198 
molecules with new functions. Their analysis revealed very different biosynthetic architectures and 199 
they posit these result from chromosomal incorporation of disparate plasmid-borne genomic islands, 200 
acquired via horizontal gene transfer, leading to bacterial biosynthesis of varying antifungal 201 
molecules with virtually identical core structures (Sit et al. 2015). In this example each effective core 202 
forms a foundation for several different antifungal variants with different efficacies. Thus natural 203 
selection favours a combination of enhanced genetic variants available for rapid evolutionary 204 
selection to retard the development of antifungal resistances (Bergstrom, Lo, and Lipsitch 2004; 205 
Baym, Stone, and Kishony 2016). We speculate that in order to synthesise an effective variability of 206 
mixed antifungals, both on short and on long evolutionary timescales, bacteria are better weapons 207 
compared with the relatively slow genetic variation/selection rates possible within arthropods.  208 
Nevertheless, perhaps further emphasising the magnitude of microbial challenge insects face, their 209 
endogenous antifungal peptides already display a remarkable evolutionary plasticity, originating from 210 
gene duplication, subsequent diversification, and de novo creation from non-coding sequences 211 
(Mylonakis et al. 2016). Horizontal gene transfer is relatively rare in metazoa (Nakabachi 2015) so 212 
specific antifungal peptide families have been identified clustered within single insect orders and 213 
restricted taxonomic groups, reflecting specific evolutionary adaptation (Mylonakis et al. 2016). 214 
Therefore, the antifungal peptides are less plastic when compared the antifungals synthesized from 215 
bacterial antifungal gene clusters. In addition, bacterial mutualists, with plastic haploid genomes, offer 216 
faster mutation rates and frequent employment of horizontal gene transfer, whilst, by comparison, n-217 
ploid arthropod reproduction/selection is slower in securing and expressing effective changes.  218 
This is particularly the case in eusocial arthropods such as attines ants. Comprising up to several 219 
million individuals harvesting vegetation to feed their cultivars, such colonies might be classed as 220 
‘super-organisms’ (Hölldobler and Edward 2009) peculiarly vulnerable to the threat parasitic fungi 221 
present. Workers spend much of their time foraging implying continual contact with genetically-222 
varied spores of fungal strains pathogenic to their mutualistic fungus cultivar (Poulsen et al. 2002). In 223 
this scenario, Escovopsis strains are potentially variable via recruitment (Poulsen et al. 2010) as well 224 
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as via their innate ability to offer genetic differentiation (De Mana et al. 2016). Their cultivar is 225 
genetically homogenous (Kooij et al. 2015) and the colony is long-lived, so potentially parasitic fungi 226 
have years to adapt to it. The colony is slow to reproduce, although one colony may survive many 227 
years and can produce many alates a year, it may require five years or more before it is capable of 228 
their production and can never gain the equivalent benefits of multiple offspring/multiple generation 229 
breeding strategies that short-lived insects enjoy (Keller and Genoud 1997). Other factors are also 230 
influential: multi-mated queens notwithstanding, workers possess relative high genetic homogeneity 231 
(Holzer, Keller, and Chapuisat 2009), limiting the range of endogenous antifungals any one colony 232 
can produce whilst living underground in humid, fungus-friendly environments encourages invasion 233 
by other competing/parasitic fungi  (Pie, Rosengaus, and Traniello 2004). 234 
Thus, such eusocial insect colonies experience many of the disadvantages of a long-lived complex 235 
organism’s long-term interactions with pathogens without the benefit of its more advanced, adaptive, 236 
‘memory-driven’ immune system (Gross et al. 2009). Bacteria and fungi have been antagonists for 237 
millennia and have evolved sophisticated compound spectra by which to inhibit/destroy each other so 238 
it is entirely understandable that some eusocial insects, depending upon long-term mutualistic 239 
relationships with fungi, would exploit antifungal-producing bacteria as a form of colonial/’super-240 
organismal’ ‘immune system’ (Penick et al. 2018). Thus, in lieu of rapid reproduction providing 241 
continual variation in immunity or a system of adaptive immunity, the attines (and others of their 242 
eusocial ilk) exploit bacteria as anti-pathogenic defence systems to the extent that they are dependent 243 
upon them.  244 
The virtue of these mutualistic bacteria, with Pseudonocardia prominent amongst them, is that they 245 
are genetically-specialised to offer continual production of varied self-similar but non-repeating 246 
antifungal compound assemblages (Pathak, Kett, and Marvasi 2019). By so doing they produce 247 
stochastically-varying anti-fungal conditions to which parasitic fungi cannot respond with sufficient 248 
rapidity to ‘outwit’; a ‘Red Queen environment’ to keep them evolutionarily outmanoeuvred.  249 
It is therefore important to find out whether single-drug–resistance steps would be selected for or 250 
against in a multidrug environment. We speculate that mixtures of bacterial antifungal variants would 251 
help ants’ antifungal peptides retain their efficacy, delaying the parasite’s antifungal resistance. The 252 
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first important assumption is that antibiotic interactions can change with the acquisition of particular 253 
mutations (leading to resistance) (Baym, Stone, and Kishony 2016). In Figure 2, three models are 254 
proposed. In the Induced Synergy Model (Figure 2 A) ants’ antifungal peptides act in synergy with 255 
the bacterial antifungal mixtures. In this model the parasite may develop an antifungal peptide-256 
resistance allele which, whilst conferring resistance to the antifungal peptide, also changes its 257 
interaction with the bacterial antifungal mixture, making the resistant parasite more sensitive to the 258 
overall treatment. This principle has been established in other contexts, such as in Escherichia coli 259 
and cell lung cancer lines resistant to chemotherapeutics (Wood et al. 2014). Efficacy persistence of 260 
bacterial antifungal mixtures is greater than that of individual compounds, so that complexes of 261 
antifungal peptides isolated from maggots of Calliphoridae flies prevent development of resistance 262 
better than their individual component small molecules and peptides (Chernysh, Gordya, and 263 
Suborova 2015). The second model (Figure 2 B) shows the collateral sensitivity which occurs without 264 
co-application of the bacterial antifungal and the antifungal peptide. Mutant alleles conferring 265 
resistance to antifungal peptides induce susceptibility to the bacterial antifungal (Baym, Stone, and 266 
Kishony 2016). In the third model (Figure 2, C), the two molecules interact, and the sensitive 267 
microorganisms can grow at high concentrations of bacterial antifungal when the peptide antifungal is 268 
also present. However, the efficacy of bacterial antifungals is reduced due to the evolution of 269 
resistance to co-applied antifungal peptide. In all these contexts cycling of bacterial antifungal 270 
mixtures may prevent the parasite’s escape towards resistance. Thus, the rapidity of bacterial 271 
antibiotic evolutionary rate does not solely rely on antibiotic cycling. Cycling utilises 272 
a recurring series of antibiotics, but antibiotic production by Pseudonocardia (or other 273 
microorganisms) is unlikely to exhibit a cyclic development, rather it produces unpredictable, non-274 
repetitive compound variants over time (Pathak, Kett, and Marvasi 2019).  275 
This interaction may be considered a Chase Red Queen (CRQ) scenario, in which local directional 276 
selection drives coevolutionary chases between exploiter (bacteria) and victim (arthropods’ fungal 277 
parasites)  phenotypes (Brockhurst et al. 2014). CRQ dynamics generally occur when interactions 278 
have a complex genetic basis; in this case the acquisition, exchange and recombination of genes 279 
related to antifungal synthesis by bacteria. This results in a chase in multiple ways. In the attine-280 
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cultivar scenario both the pathogen and host cover the same role: hosts are under selection to increase 281 
phenotypic distance through de novo evolution of novelty, while exploiters are under selection to 282 
reduce phenotypic distance (Brockhurst et al. 2014). In the attine-cultivar the CRQ imposes a 283 
coevolution process comprising a continual series of selective sweeps, which reduce genetic diversity 284 
within populations but that drive divergence between populations. The extent to which this operates in 285 
arthropod-bacterial mutualisms should be clarified in further experiments assessing genetic diversity 286 
of the microbiome across nests and metagenomics and metatassonomic diversity (Lozupone et al. 287 
2007). Sustained cycles of coevolutionary chase may occur through phenotype space whereby the 288 
direction and intensity of selection vary according to the relative locations of the species in phenotype 289 




Figure 1. Mechanisms preventing development of antifungal resistance.  In this example, ants can 294 
release a range of both endogenous and bacterial antifungals. 295 
Bacteria can exploit genetic changes resulting from horizontal gene transfer, gene rearrangement, 296 
mutation and haploidy plus rapid reproduction to produce quickly changing antifungal mixtures.  297 
Ants do not reproduce as fast as bacteria, have much lower population numbers and more 298 
homogenous genes. They can, however, produce a range of antimicrobial peptides (AMPs) with 299 
antifungal activity to act as an effective first defence. 300 
 301 
Figure 2. Strategies for preventing development of antifungal resistance. The models are 302 
particular cases from those proposed by Baym et al. (2016). In this context the two key players are 303 
AMPs produced by insects and antifungals produced by bacteria.  (A) In a synergistic antagonistic 304 
interaction acquisition of resistance makes the mutant more sensitive to the combination of the 305 
antimicrobial peptide and bacterial antifungal. (B) In the collateral sensitivity hypothesis, which 306 
occurs without co-application, acquired resistance to AMPs induce susceptibility of the bacterial 307 
antifungal thus allowing selection against resistance. (C) In a suppressive interaction strategy, due to 308 
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molecular interaction of the bacterial antifungals and antifungal peptides, efficacy of bacterial 309 
antifungals is reduced as the resistance to antimicrobial peptide evolves. Figure modified from Baym 310 
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